Dietz V. Homeopathic and herbal preparations of Arnica montana for treatment of musculoskeletal injuries. Integr Med 1998; 1: 42-4.
Committee for veterinary medicinal products-Arnica montana. European agency for the evaluation of medicinal products, veterinary medicinal evaluation unit. 1999
Majoie B. Process for obtaning an extract of Arnica montana. US 3832343, 1974.
Durand GAH, Durand F. Plant extract obtained by an extraction method by means of solvents of plant origin. US20090306386, 2009.
Kratz F. Combination of drugs with protein-binding prodrugs. EP2560688, 2013.
Jordan A, Waldoefner N, Scholz R. Method for encapsulating therapeutic substances in cells. CA2619278, 2007.
Yosuke T, Hiroshi T, Shinjiro S. Cell death induction reagent, cell inhibitory effect reagent and for treat by the extremely caused disease of cell Proliferation medical composition. CN108064172, 2018.
Attardo GG, Belleau B. Heteroanthracycline antitumor analogs. ZA199201121, 1993.
Howes MR. Prooxidant cancer chemo-suppressors and chemo-protectors and methods of use related thereto. US20190275119, 2019.
Brunner L, Dirix Y, Jani S, Tommasini R. Medical implant producing wear particles with benign body response. WO2010096053, 2009.
Qazi NG, Taneja CS, Singh J, et al. Semi-synthetic sesquiterpene lactone parthenin compound useful for cytotoxicity against cancer cell lines and anticander agent. WO2009122447, 2009.
Finley C, Bestwick PH. Cannabis oil compositions and methods for preparation thereof. CA3006182, 2017.
Harikumar KB. Complementary and Alternative Medicines in Prostate Cancer: A comprehensive review. 1st ed. CRC Press: Boca Raton, FL, USA 2016.
Inohara S, Kishida N, Konishi M. Androgen receptor-binding inhibitor. JP2007230916, 2010.
Helgason C, Crea F, Wang Y, et al. Methods and uses for diagnosis and treatment of prostate cancer. WO2014205555, 2014.
Cagir A, Kasapler P, Cakmak YO. A new class of highly apoptotic anti-cancer agents. WO2011099947A1
Attardo GG, Belleau B. Heteroanthracycline antitumor analogs. US5348946A , 1994.
Lui NILO, Lee WKT. Combination use of CD47 antibodies/inhibitors with sorafenib for treatment of liver cancer. US20170071918, 2017.
Gorman J. Novel regimens for treating diseases and disorders. US20080019975, 2008.
Faustman LD. Methods for expansion or depletion of t-regulatory cells. US20180161370, 2018.
Kratz F, Merfort I. Dual acting prodrugs. WO2008098789, 2008.
Reid BC, Collins TQ. Compositions of natural extracts and use thereof in methods for preventing or treating diseases. US20190224193, 2017.
Hans-Eric C, Magnus B. Use of Ltb4 inhibitors for the treatment of b-cell leukemias and lymphomas. US20080081835, 2008.
Dudakov J, Kinsella S. Compositions and methods to promote thymic regeneration. WO2019140300, 2019.
Huang H. Methods and materials for treating cancer. WO2019169145A1 , 2019.
Tergaonkar V. Telomerase inhibitors for use in therapy. US20150232856, 2015.
Doi K. Agent for inhibiting increase in expression of stem cell factor and agent for inhibiting increase in expression of basic fibroblast growth factor. JP2008169118, 2008.
Korsun BF, Kuhara PS. Agent for treatment of patients with uterus myoma as hormone-dependent tumor and method of its realization. RU2145232, 2000.
Solecki B. Cannabis root extract, method of manufacture, method of use. WO2019195943, 2019.
Mc Clung HJ. Composition for topical application to skin. US6579543, 2003.
Bebirakuadamute MP, Seronos BM. Systems and methods for characterizing a biological condition or agent using calibrated gene expression profiles. KR20020079364, 2002.
Polich JN. Homeopathic therapeutic method and compositions. US20160324910, 2016.
Kurzrock R, Li L, Mehta K, Aggarawal BB, Helson L. Liposomal curcumin for treatment of diseases. US20140322303, 2014.
Aioi A. Inflammatory mediator production inhibitor and skin care agent for external use containing the same. JP2011178705, 2011.
Paradise L. Homeopathic pharmaceutical compositions. US5795573, 1998.
Archer KH, Pettit SM. Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery. US 5976547, 1999.
Garruto AJ, Widgerow DA. Compositions and methods for invasive and non-invasive procedural skincare. US10286030, 2019.
Costin JM, Williams JM. Compositions and methods for treating and preventing joint pain. WO2019106574, 2019.
Elliot P. Methods for treatment of inflammatory diseases. US20010003753, 2001.
Li Liu. Traditional chinese medicine liquid for treating skin itch and preparation method. CN103893495, 2014.
Babish J, Howell T, Pacioretty L. Compositions exhibiting synergistic inhibition of the expression and/or activity of clyclooxygenase-2. US20020077350, 2002.
Oswal DG, Oswal GP. A homeopathic formulation. EP2296681, 2011.
Roland L. Nasal spray containing a plant extract for the treatment of diseases such as herpes zoster, hematoma, mastitis and cardiovasculatory weakness. EP1374883, 2004.
Gabriele V. Cyclohexyl carbamate compounds as skin and/or hair lightening actives. EP2593077, 2016.
Grollier FJ, Alec J, Fourcadier C, Rosenbaum G, Darmenton P. Cosmetic composition for the treatment of the hair and skin comprising a powder of flowers or flower tops and a cohes on agen. US4459285, 1984.
Schneider E, Ferone J. Skin care preparation. US4973473A, 1990.
Soudant E, Nadaud J. Use of a growth factor in a slimming composition. US5436230, 1995.
Bissette LD. Method of reducing cellulite in mamalian skin. US5962482, 1999.
Kirzinger H. Anti-stress agents for aquatic animals. US6306453, 2001.
Tyrrell D Lange B Krzysik D. Antioxidant-containing wipes and absorbent products. WO2004045575, 2004.
Hersh T. Reparatives for chemosurgery and laser (thermal) therapy. US6630442B1, 2003.
Forman Y, Maabarot K, Levin O, Friedman D, Friedman KM. Effervescent granules. US59484397, 1999.
Hoffmann H, Roreger M. Hydrophilic pressure sensitive hot-meltadhesives. US6190689, 2001.
Dirksing SR, Errey JP, Johnson LT. Cosmetic or dermapharmaceutical patch. WO2001001816, 2001.
Alam M. Topical Arnica treatment for reducing bruising. US20090104292, 2009.
Yichun L. Nasal sticker for removing blackheads and shrinking pores. CN106511201, 2017.
Assessment report on Arnica montanaL. flos. European Medicines Agency (Science medicines agency) EMA/HMPC/198794/2012, 2012; 1-25.
Baillargean L, Drouin J, Desjardins L, Leroux D, Audet D. The effects of Arnica montana on bleeding time. A randomized clinical trial. Biomed Therap 1998; 16: 272-6.
Goedemans A, Liang K, Bennett PN. Topical Arnica and mucopolysaccharide polysulfate (Hirudoid) to decrease bruising and pain associated with haemodialysis cannulation related infiltration: A pilot study. Renal Soc Australas J 2014; 10: 62-5.